Coastline Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-207
Closed -$8.84K – 353
2026
Q2
$8.84K Sell
207
-290
-58% -$15.7K ﹤0.01% 369
2026
Q1
$31.2K Buy
+497
New +$39.8K ﹤0.01% 308
2025
Q1
– Sell
-20
Closed -$1.79K – 402
2024
Q4
$1.79K Buy
+20
New +$1.76K ﹤0.01% 404
2023
Q2
– Sell
-5,250
Closed -$263K – 280
2023
Q1
$263K Buy
+5,250
New +$247K 0.04% 262
2022
Q2
– Sell
-8,010
Closed -$355K – 316
2022
Q1
$355K Hold
8,010
– – 0.04% 274
2021
Q4
$340K Hold
8,010
– – 0.04% 285
2021
Q3
$348K Hold
8,010
– – 0.04% 269
2021
Q2
$343K Hold
8,010
– – 0.04% 274
2021
Q1
$310K Hold
8,010
– – 0.04% 284
2020
Q4
$288K Sell
8,010
-3,300
-29% -$119K 0.04% 286
2020
Q3
$432K Buy
11,310
+2,310
+26% +$89K 0.06% 245
2020
Q2
$316K Hold
9,000
– – 0.05% 263
2020
Q1
$294K Sell
9,000
-1,000
-10% -$39.1K 0.05% 261
2019
Q4
$452K Buy
10,000
+1,000
+11% +$41.8K 0.06% 260
2019
Q3
$366K Buy
+9,000
New +$381K 0.05% 271

Other funds holding BSX

Coastline Trust's BSX Position: Q3 2026 in Review

Coastline Trust sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 207 shares — an estimated $8.84K sold.

Coastline Trust first reported a position in BSX in Q3 2019 and held it in 15 quarters. The position peaked at $452K in Q4 2019. 43 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Coastline Trust reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • Coastline Trust sold 207 Boston Scientific shares in Q3 2026, an estimated $8.84K.
  • Coastline Trust first reported a position in Boston Scientific in Q3 2019 and held it in 15 quarters.
  • Coastline Trust's Boston Scientific position peaked at $452K in Q4 2019.
  • 43 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Coastline Trust's 13F filing for Q3 2026, filed 1 Oct 2026.